GDF15 Ameliorates Deoxynivalenol‐Induced Anemia by Resolving Ribosomal Stress–Mediated Erythropoietic Arrest
Advanced Science · 2025
DOI: 10.1002/advs.202509265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yan Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, 450000, China. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Trichothecenes, Erythropoiesis, Anemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Program for Science and Technology Innovation Talents in Universities of Henan Province, Science and Technology Development Program of Henan Province.
Abstract (Originalsprache)
Deoxynivalenol (DON) is a prevalent trichothecene mycotoxin that contaminates global food supplies, posing significant health risks; however, targeted therapies against DON are scarce. Although DON‐induced anemia is well‐documented, the underlying mechanisms remain unclear. In this study, the effects of DON on erythropoiesis are examined in detail using complementary murine models and human primary erythroid cultures. DON impaired erythropoiesis by disrupting hematopoietic homeostasis as well as erythroid commitment and differentiation via ribosomal stress–mediated cell cycle arrest. Multi‐omics analyses revealed that the effects of DON are attributed to ribosomal dysfunction, which selectively disrupted protein synthesis without altering mRNA expression. Mechanistically, DON downregulated translation of growth differentiation factor 15 (GDF15) along with decreases in β‐catenin, Myc, and p21. Importantly, GDF15 supplementation rescued DON‐induced erythropoietic defects in vitro and in vivo, restored levels of β‐catenin, Myc, and p21, and cell cycle progression, indicating DON inhibits erythropoiesis via the GDF15–β‐catenin–Myc–p21 axis. These findings elucidate the pathogenesis of DON‐induced anemia and identify GDF15 as a novel therapeutic target against mycotoxin poisoning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, 450000, China.
- Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, 450008, China.
- Laboratory of Membrane Biology, New York Blood Center, New York, NY, 10065, USA.
ORCID-Profile: Shijie Zhang
Förderung
- National Natural Science Foundation of China
- Program for Science and Technology Innovation Talents in Universities of Henan Province
- Science and Technology Development Program of Henan Province
Zitieren
APA
Li, Y., Jia, P., Zhang, J., Zhang, H., Li, B., Chang, J., Li, Y., Zhao, L., Zhen, Y., Zheng, T., Xu, Y., An, X., & Zhang, S. (2025). GDF15 Ameliorates Deoxynivalenol‐Induced Anemia by Resolving Ribosomal Stress–Mediated Erythropoietic Arrest. Advanced Science. https://doi.org/10.1002/advs.202509265
Vancouver
Li Y, Jia P, Zhang J, Zhang H, Li B, Chang J, et al. GDF15 Ameliorates Deoxynivalenol‐Induced Anemia by Resolving Ribosomal Stress–Mediated Erythropoietic Arrest. Advanced Science. 2025. doi:10.1002/advs.202509265
BibTeX
@article{Li2025,
author = {Li, Yan and Jia, Peijun and Zhang, Jingxin and Zhang, Huan and Li, Bing and Chang, Jiawei and Li, Yating and Zhao, Longzhen and Zhen, Yazhe and Zheng, Tingting and Xu, Yuanlin and An, Xiuli and Zhang, Shijie},
title = {GDF15 Ameliorates Deoxynivalenol‐Induced Anemia by Resolving Ribosomal Stress–Mediated Erythropoietic Arrest},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202509265}
}
EUVIMED